28 JULY 2005

NEW ZEALAND GAZETTE, No. 112

associated with emergency contraception by pharmacists
or nurses accredited to sell levonorgestrel for emergency
contraception
Propantheline
Protamine sulfate
Quinisocaine
Sabadilla; except when specified elsewhere in the Schedule
Sevelamer
Strontium ranelate
Strychnos spp
Tenofovir
Terlipressin
Thiomesterone
Thiourea; except in medicines containing 0.1% or less
Treprostinil
Trichloroacetic acid; except for external use in medicines
containing 12.5% or less for the treatment of warts other
than anogenital warts
Vardenafil
Ximelagatran

Schedule 2

Restricted Medicines

Ciclopirox; for dermal use in medicines containing more
than 2%
Diclofenac; in solid dose form containing 25 milligrams
or less and more than 12.5 milligrams per dose form in
packs of not more than 30 tablets or capsules
Erythryl tetranitrate

*Fluconazole; for oral use in medicines which have received
the consent of the Minister or the Director-General to
their distribution as restricted medicines and are sold
in the manufacturer’s original pack containing 150
milligrams or less as a single dose for the treatment of
vaginal candidiasis

Fluorides; in pastes, gels or powders for cleaning the teeth
containing more than 0.1%
Glyceryl trinitrate; for oral or sublingual use
Haemophilus influenzae vaccine; in oral vaccines for the
prophylaxis of bacterial complications of colds
Hyoscine butylbromide; for oral use in medicines containing
not more than 10 milligrams per dose form and in packs
containing not more than 20 tablets or capsules
Ketotifen; for ophthalmic use in medicines containing
0.025% or less
Mannityl hexanitrate
Orlistat; in medicines containing 120 milligrams or less
per dose form
Pneumococcal vaccine; in oral vaccines for the prophylaxis
of bacterial complications of colds
Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing 1%
or less and more than 0.5%
Podophyllum emodi; for external use for the treatment of
warts other than anogenital warts in medicines containing
20% or less and more than 10% of podophyllin
Podophyllum peltatum; for external use for the treatment of
warts other than anogenital warts in medicines containing
20% or less and more than 10% of podophyllin
Prochlorperazine; in packs containing not more than
10 tablets for the treatment of nausea associated
with migraine
Salicylic acid; in medicines containing more than 40%
Silver sulfadiazine; except for external use in packs
containing 50 grams or less

2709

Sodium picosulfate; in preparations for bowel cleansing prior
to diagnostic, medical or surgical procedures
Triamcinolone; for buccal use in medicines containing 0.1%
or less of triamcinolone acetonide and in pack sizes no
greater than 5 grams

Schedule 3

Pharmacy-only Medicines

Acetylcysteine; for oral use in medicines containing more
than 1 gram per recommended daily dose
Aciclovir; for external use for the treatment of herpes
labialis except in medicines containing 5% or less and
in tubes containing 3 grams or less
Amethocaine; for external use in medicines containing 10%
or less and more than 2%
Atropa belladonna; for external use in medicines containing
0.03% of the alkaloids of belladonna; for oral use in
liquid form in medicines containing 0.03% or less
and 0.3 milligrams or less per dose and not more
than 1.2 milligrams per recommended daily dose of
the alkaloids of belladonna or in solid dose form in
medicines containing 0.3 milligrams or less per dose
form and not more than 1.2 milligrams per recommended
daily dose of the alkaloids of belladonna
Atropine; for oral use in liquid form in medicines containing
0.03% or less and 0.3 milligrams or less per dose and
not more than 1.2 milligrams per recommended daily
dose or in solid dose form in medicines containing
0.3 milligrams or less per dose form and not more
than 1.2 milligrams per recommended daily dose; in
medicines containing atropine sulfate for the treatment
of organophosphorous poisoning either in packs of up
to 20 tablets containing 0.6 milligrams or less per
tablet or in injections in packs of 5 or less containing
0.6 milligrams per millilitre or less; except when used as
an antidote in a device designed for self-injection; except
when sold by licensees under the Toxic Substances
Regulations

*Beclomethasone; in aqueous nasal sprays delivering up
to 50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Benzocaine; for external use in medicines containing 10%
or less and more than 2%
Benzydamine; for external use
Bifonazole; for external use except in medicines for tinea
pedis only or in shampoos containing 1% or less

*Budesonide; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Ciclopirox; for dermal use in medicines containing 2% or
less except in medicines for tinea pedis only
Cinchocaine; for external use in medicines containing 0.5%
or less
Datura spp; for oral use in liquid form in medicines
containing 0.03% or less and 0.3 milligrams or less per
dose and not more than 1.2 milligrams per recommended
daily dose of total solanaceous alkaloids or in solid
dose form in medicines containing 0.3 milligrams or less
per dose form and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
Dextromethorphan; in liquid form containing more
than 0.25% or in solid dose form containing more than
15 milligrams per dose form when in packs containing